Charles River Laboratories Stock Performance
| CRL Stock | USD 197.05 4.70 2.33% |
Charles River has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 2.56, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Charles River will likely underperform. Charles River Labora right now shows a risk of 2.71%. Please confirm Charles River Labora coefficient of variation, semi variance, period momentum indicator, as well as the relationship between the treynor ratio and daily balance of power , to decide if Charles River Labora will be following its price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Charles River Laboratories are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Charles River is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors. ...more
Actual Historical Performance (%)
One Day Return (2.33) | Five Day Return 1.68 | Year To Date Return (15.88) | Ten Year Return 212.88 | All Time Return 795.68 |
1 | Acquisition by Richard Wallman of 1311 shares of Charles River at 228.41 subject to Rule 16b-3 | 10/08/2024 |
2 | Charles River Laboratories International Rating Lowered to Hold at StockNews.com | 10/10/2024 |
3 | Clinical Trials Market Size to Reach 73.33 Billion By 2031 CAGR 6.8 percent The Insight Partners | 10/28/2024 |
4 | Cell And Gene Therapy Market Size to Worth USD 190.82 Billion by 2033 Straits Research | 11/07/2024 |
5 | Charles River International Revenue in Focus Trends and Expectations | 11/11/2024 |
6 | Disposition of 4500 shares by James Foster of Charles River subject to Rule 16b-3 | 11/12/2024 |
7 | Charles River Laboratories International, Inc. Shares Purchased by Venturi Wealth Management LLC | 11/13/2024 |
8 | Biopharmaceuticals Manufacturing Consumables Industry Research Report 2024-2030 Growing Demand for API Testing Fueling Growth, Shift Toward Large Biological Mol... | 11/19/2024 |
9 | King Luther Capital Management Corp Cuts Holdings in Charles River Laboratories International, Inc. | 11/22/2024 |
10 | Charles River Labs shares target cut, rating held on Q2 results | 11/25/2024 |
11 | While shareholders of Charles River Laboratories International are in the red over the last three years, underlying earnings have actually grown | 11/26/2024 |
12 | Disposition of 1304 shares by Joseph LaPlume of Charles River at 226.97 subject to Rule 16b-3 | 12/02/2024 |
13 | Why Is Charles River Down 8.9 percent Since Last Earnings Report | 12/06/2024 |
14 | Charles River Laboratories International, Inc. Stock Holdings Trimmed by Fmr LLC - MarketBeat | 12/10/2024 |
| Begin Period Cash Flow | 241.2 M |
Charles |
Charles River Relative Risk vs. Return Landscape
If you would invest 19,432 in Charles River Laboratories on September 12, 2024 and sell it today you would earn a total of 273.00 from holding Charles River Laboratories or generate 1.4% return on investment over 90 days. Charles River Laboratories is generating 0.0573% of daily returns assuming volatility of 2.7105% on return distribution over 90 days investment horizon. In other words, 24% of stocks are less volatile than Charles, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Charles River Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Charles River's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Charles River Laboratories, and traders can use it to determine the average amount a Charles River's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0211
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | CRL | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.71 actual daily | 24 76% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Charles River is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Charles River by adding it to a well-diversified portfolio.
Charles River Fundamentals Growth
Charles Stock prices reflect investors' perceptions of the future prospects and financial health of Charles River, and Charles River fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Charles Stock performance.
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0487 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 12.87 B | ||||
| Shares Outstanding | 51.14 M | ||||
| Price To Earning | 33.74 X | ||||
| Price To Book | 2.73 X | ||||
| Price To Sales | 2.54 X | ||||
| Revenue | 4.13 B | ||||
| Gross Profit | 1.46 B | ||||
| EBITDA | 1.03 B | ||||
| Net Income | 480.37 M | ||||
| Cash And Equivalents | 233.91 M | ||||
| Cash Per Share | 3.96 X | ||||
| Total Debt | 3.07 B | ||||
| Debt To Equity | 1.27 % | ||||
| Current Ratio | 1.33 X | ||||
| Book Value Per Share | 73.97 X | ||||
| Cash Flow From Operations | 683.9 M | ||||
| Earnings Per Share | 8.00 X | ||||
| Market Capitalization | 10.32 B | ||||
| Total Asset | 8.2 B | ||||
| Retained Earnings | 1.89 B | ||||
| Working Capital | 553.58 M | ||||
| Current Asset | 559.23 M | ||||
| Current Liabilities | 311.76 M | ||||
About Charles River Performance
By examining Charles River's fundamental ratios, stakeholders can obtain critical insights into Charles River's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Charles River is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 42.72 | 51.45 | |
| Return On Tangible Assets | 0.13 | 0.12 | |
| Return On Capital Employed | 0.10 | 0.11 | |
| Return On Assets | 0.06 | 0.06 | |
| Return On Equity | 0.16 | 0.15 |
Things to note about Charles River Labora performance evaluation
Checking the ongoing alerts about Charles River for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Charles River Labora help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Charles River Labora is unlikely to experience financial distress in the next 2 years | |
| Charles River Labora has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Charles River Laboratories International, Inc. Stock Holdings Trimmed by Fmr LLC - MarketBeat |
- Analyzing Charles River's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Charles River's stock is overvalued or undervalued compared to its peers.
- Examining Charles River's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Charles River's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Charles River's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Charles River's stock. These opinions can provide insight into Charles River's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Charles River Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Charles River. If investors know Charles will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Charles River listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.21) | Earnings Share 8 | Revenue Per Share 78.97 | Quarterly Revenue Growth (0.02) | Return On Assets 0.0487 |
The market value of Charles River Labora is measured differently than its book value, which is the value of Charles that is recorded on the company's balance sheet. Investors also form their own opinion of Charles River's value that differs from its market value or its book value, called intrinsic value, which is Charles River's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Charles River's market value can be influenced by many factors that don't directly affect Charles River's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Charles River's value and its price as these two are different measures arrived at by different means. Investors typically determine if Charles River is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Charles River's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.